BlephaCura
Commercial- Indications
- Ophthalmological disorders
Company intelligence / Profile preview
Optima Pharmazeutische
Schwäbisch Hall, Baden-Württemberg, Germanyoptimapharma.de ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
Decades of experience with a focus on ophthalmology and otolaryngology; more than 30 peer-reviewed publications about efficacy of their products exist. No traditional clinical trial pipeline for drugs.
- Therapeutic areas
- OtherPulmonologyOphthalmology
- Modalities
- DeviceMedical device-based therapies
- Industry
- Therapeutic Medical Devices
02
Drug pipeline
3 assets2 more assets in the full pipeline.
Request access →03
Partnerships
Collaborations with prestigious scientific institutions for research/publication purposesISPE Gold Partner since 2024
Beyond the preview
Go deeper on Optima Pharmazeutische.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Optima Pharmazeutische.